Stocktoria

QuidelOrtho Corp QDEL

Nasdaq · stock · In Vitro & In Vivo Diagnostic Substances · website · IPO 1991-02-01 · LEI

QuidelOrtho Corp statistics & valuation

Market cap$940.4M
P / S0.3×
P / B0.5×
Net margin-41.5%
Return on equity-58.9%
FCF margin-3.0%
Net debt$2.5B
Enterprise value USD$3.5B
Earnings yield EBIT/EV-26.5%
Return on capital-19.1%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
41.50% 16.80% -0.30% -73.70% -41.50% 20222023202320242025
Gross margin (%)
20222023202320242025
Operating margin (%)
53.30% 25.80% 4.60% -70.50% -33.70% 20222023202320242025
Return on equity (%)
36.50% 11.10% -0.20% -68.80% -58.90% 20222023202320242025
Shares outstanding
42.9M 66.4M 66.8M 67.3M 67.9M 20222023202320242025
Net debt ($)
$2.36B $2.30B $2.39B $2.53B 20222023202320242025
Share buybacks ($)
20222023202320242025
Return on assets (%)
29.00% 6.20% -0.10% -31.90% -19.60% 20222023202320242025
Free cash flow margin (%)
30.20% 22.80% 2.40% -4.00% -3.00% 20222023202320242025
Debt / equity (×)
0.54× 0.48× 0.83× 1.40× 20222023202320242025
EPS ($)
$16.43 $9.56 -$0.15 -$30.54 -$16.69 20222023202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2023FY2022
Operating margin-33.7%-70.5%4.6%25.8%53.3%
Net margin-41.5%-73.7%-0.3%16.8%41.5%
FCF margin-3.0%-4.0%2.4%22.8%30.2%
Return on assets-19.6%-31.9%-0.1%6.2%29.0%
Return on equity-58.9%-68.8%-0.2%11.1%36.5%
Debt / equity1.40×0.83×0.48×0.54×—
Current ratio1.501.221.571.564.45

Computed from company filings · US · as of 2025-12-28. Facts plus Stocktoria's own computed scores — not investment advice.